NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as C$5.77 and last traded at C$5.74, with a volume of 262359 shares. The stock had previously closed at C$5.72.
Analyst Upgrades and Downgrades
NWH.UN has been the topic of several recent research reports. Royal Bank Of Canada set a C$5.50 price target on shares of NorthWest Health Prop Real Est Inv Trust and gave the stock a “sector perform” rating in a research report on Monday, November 24th. BMO Capital Markets upped their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research note on Thursday, November 13th. CIBC raised their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a report on Thursday, November 13th. Finally, Scotiabank boosted their price target on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a report on Thursday, November 13th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of C$6.00.
Read Our Latest Report on NWH.UN
NorthWest Health Prop Real Est Inv Trust Price Performance
NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) last released its quarterly earnings results on Tuesday, November 11th. The company reported C$0.06 EPS for the quarter. The company had revenue of C$110.69 million for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative return on equity of 14.67% and a negative net margin of 75.29%. Sell-side analysts forecast that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 earnings per share for the current year.
NorthWest Health Prop Real Est Inv Trust Company Profile
Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.
Featured Articles
- Five stocks we like better than NorthWest Health Prop Real Est Inv Trust
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Gold’s getting scarce.
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.
